Islamabad: Pakistan’s economy has posted a growth of 5.66 percent during the fourth quarter of Fiscal Year 2025. According to Radio Pakistan, the updated growth rate of GDP for Fiscal Year 2025 is 3.04 percent as compared to 2.68 percent estimated previously. The overall size of the economy stands at
Lahore: The first batch of South Africa’s Test cricket squad has arrived in Lahore to play a two-Test Match series against Pakistan. The arrival marks the beginning of preparations for the much-anticipated series as the teams gear up for the first Test match. According to Radio Pakistan, the second batch
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer Leave a reply Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer Leave a reply Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates
Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, a biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched today with a $101 million
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer Leave a reply Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer Leave a reply Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer Leave a reply Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates